Scarica l'app Stockscreener
4.20
1.69%
0.07
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.13
Aprire:
$4.19
Volume 24 ore:
281.86K
Relative Volume:
0.43
Capitalizzazione di mercato:
$223.58M
Reddito:
-
Utile/perdita netta:
$-32.94M
Rapporto P/E:
-3.7838
EPS:
-1.11
Flusso di cassa netto:
$-24.95M
1 W Prestazione:
-1.18%
1M Prestazione:
-23.91%
6M Prestazione:
+65.35%
1 anno Prestazione:
+23.89%
Intervallo 1D:
$4.14
$4.29
Intervallo di 1 settimana:
$4.00
$4.47
Portata 52W:
$1.84
$6.025
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Nome
Achieve Life Sciences Inc
Settore
Industria
Telefono
425-686-1500
Indirizzo
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
4.20 | 219.86M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-25 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-08-21 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2024-09-27 | Iniziato | Raymond James | Strong Buy |
| 2023-05-10 | Reiterato | Maxim Group | Buy |
| 2021-06-23 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
Alert wrongly tagged to Achieve Life Sciences withdrawn - marketscreener.com
Is Achieve Life Sciences Inc. stock trending bullishJuly 2025 WrapUp & Target Return Focused Stock Picks - mfd.ru
Will Achieve Life Sciences Inc. (SP4P) stock outperform small cap peersEarnings Risk Summary & Low Risk Entry Point Guides - mfd.ru
IPO Launch: What are Achieve Life Sciences Incs recent SEC filings showingQuarterly Profit Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Roivant Sciences (ROIV) - The Globe and Mail
Chipmakers Recap: What’s the profit margin of Achieve Life Sciences IncJuly 2025 Final Week & Real-Time Stock Movement Alerts - baoquankhu1.vn
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200-Day Moving AverageHere's Why - MarketBeat
Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch - Seeking Alpha
Franklin Resources Inc's Strategic Acquisition of Achieve Life S - GuruFocus
Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026Strong Buy - Seeking Alpha
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory - Finviz
Achieve Life Sciences Announced Granting of New Hire Inducement Awards - The Manila Times
Five new hires at Achieve Life Sciences get 115,000 stock options - Stock Titan
Retail Investors Who Have a Significant Stake Must Be Disappointed Along With Institutions After Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) Market Cap Dropped by US$56m - 富途牛牛
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
What is HC Wainwright's Estimate for ACHV FY2026 Earnings? - MarketBeat
FY2030 Earnings Forecast for ACHV Issued By HC Wainwright - Defense World
What is HC Wainwright's Forecast for ACHV FY2030 Earnings? - MarketBeat
Achieve Life Sciences may offer up to $300 million in securities - marketscreener.com
Achieve Life Sciences May Offer Up To $300 Million In Securities - TradingView
Achieve Life Sciences (ACHV) Announces $300M Securities Shelf Registration - GuruFocus
Achieve Life Sciences Files $300 Million Mixed Shelf - marketscreener.com
Portfolio Update: What are Achieve Life Sciences Incs recent SEC filings showingTrade Risk Assessment & Stepwise Swing Trade Plans - baoquankhu1.vn
Fed Watch: Will Achieve Life Sciences Inc benefit from sector rotationJuly 2025 Review & Stepwise Trade Signal Guides - baoquankhu1.vn
Achieve Life Sciences (NASDAQ:ACHV) Stock Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Aug PostEarnings: Is Achieve Life Sciences Inc stock trending bullishPortfolio Return Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Quarterly Earnings: Is Achieve Life Sciences Inc forming a breakout patternShort Setup & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near Future - Yahoo Finance
Whats the fair value of Achieve Life Sciences Inc stockAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Achieve Life Sciences’ smoking treatment likely to be approved by FDA, says Hunterbrook - MSN
Achieve Life Sciences appoints Mark Rubinstein as permanent CMO By Investing.com - Investing.com Nigeria
Achieve Life Sciences Promotes Mark Rubinstein As Chief Medical Officer - Nasdaq
Achieve Life Sciences (ACHV) Appoints New Chief Medical Officer - GuruFocus
Achieve Life Sciences appoints Mark Rubinstein as permanent CMO - Investing.com
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer - The Manila Times
Achieve Life Sciences Confirms Mark Rubinstein as Chief Medical Officer - Quiver Quantitative
Achieve Life Sciences, Inc. Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer - marketscreener.com
Can Achieve Life Sciences Inc. stock continue upward trendPortfolio Gains Report & AI Enhanced Trading Alerts - Улправда
Why Achieve Life Sciences Inc. stock is recommended by analystsJuly 2025 Market Mood & Weekly Top Stock Performers List - Улправда
Will Achieve Life Sciences Inc. stock benefit from automation2025 Bull vs Bear & Proven Capital Preservation Methods - Улправда
Can Achieve Life Sciences Inc. stock resist sector downturns2025 Trading Volume Trends & Long-Term Capital Growth Strategies - Улправда
Is Achieve Life Sciences Inc. stock undervalued vs historical averages2025 Bull vs Bear & Expert Curated Trade Setups - ulpravda.ru
How supply chain issues affect Achieve Life Sciences Inc. stockGlobal Markets & Momentum Based Trading Ideas - ulpravda.ru
Will Achieve Life Sciences Inc. stock outperform value stocks2025 Geopolitical Influence & High Win Rate Trade Tips - Улправда
Will Achieve Life Sciences Inc. stock deliver strong dividend growth2025 Sector Review & Smart Swing Trading Alerts - Улправда
Achieve Life Sciences, Inc.Common Shares (NQ: ACHV - FinancialContent
Achieve Life Sciences gets new interim chief medical officer - MSN
11 creative campaigns to know about today - Ad Age
Achieve Life Sciences Inc Azioni (ACHV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Achieve Life Sciences Inc Azioni (ACHV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Oki Mark K | Chief Financial Officer |
Sep 18 '25 |
Sale |
2.92 |
50,060 |
146,175 |
127,940 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Option Exercise |
0.00 |
297,500 |
0 |
358,376 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Sale |
2.92 |
129,501 |
378,143 |
228,875 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
34,100 |
0 |
46,764 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Sale |
2.77 |
14,070 |
38,974 |
32,694 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Option Exercise |
0.00 |
455,000 |
0 |
455,000 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Sale |
2.77 |
139,858 |
387,407 |
315,142 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Option Exercise |
0.00 |
110,000 |
0 |
143,214 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Sale |
2.77 |
27,629 |
76,532 |
115,585 |
| Xinos Jaime | Chief Commercial Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
69,000 |
0 |
95,286 |
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):